1. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, December 2017 Subject(s): Blood DonorsDonor Selection -- standardsHepacivirusHepatitis C -- bloodHIV Infections -- bloodHIV-1RNA, Viral -- bloodBlood -- virologyBlood TransfusionDisease Transmission, Infectious -- prevention & controlNucleic Acid Amplification TechniquesPolymerase Chain ReactionHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Human immunodeficiency virus-1 infection: developing systemic drug products for pre-exposure prophylaxis Publication: Silver Spring, MD : Center for Drug Evaluation and Research, March 2019 Subject(s): Drug DevelopmentHIV Infections -- prevention & controlPre-Exposure ProphylaxisAdolescentChildClinical Trials as TopicHIV Infections -- drug therapyHIV-1InfantHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
